We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hatch-Waxman Reforms Would Have Generics Pick A Lane
Hatch-Waxman Reforms Would Have Generics Pick A Lane
Challengers of brand name drug patents would have to choose between litigating under Hatch-Waxman or through inter partes review under legislation introduced in both the Senate and House on Wednesday.